OMNIPAQUE is a Intravascular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Ge Healthcare Inc.. The primary component is Iohexol.
Product ID | 0407-1401_1f744058-0ffe-4096-82c1-a665d90ef341 |
NDC | 0407-1401 |
Product Type | Human Prescription Drug |
Proprietary Name | OMNIPAQUE |
Generic Name | Iohexol |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVASCULAR; INTRAVENOUS |
Marketing Start Date | 2004-05-25 |
Marketing Category | NDA / NDA |
Application Number | NDA018956 |
Labeler Name | GE Healthcare Inc. |
Substance Name | IOHEXOL |
Active Ingredient Strength | 140 mg/mL |
Pharm Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2004-05-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA018956 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2004-05-25 |
Marketing Category | NDA |
Application Number | NDA018956 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2004-05-25 |
Marketing End Date | 2010-10-14 |
Marketing Category | NDA |
Application Number | NDA018956 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2004-05-25 |
Marketing End Date | 2010-10-14 |
Ingredient | Strength |
---|---|
IOHEXOL | 140 mg/mL |
SPL SET ID: | eee15ebe-d349-4497-acef-6abe7a8247fb |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
0407-1401 | OMNIPAQUE | Iohexol |
0407-1411 | OMNIPAQUE | Iohexol |
0407-1412 | OMNIPAQUE | Iohexol |
0407-1413 | Omnipaque | Iohexol |
0407-1414 | Omnipaque | Iohexol |
0407-1415 | OMNIPAQUE | OMNIPAQUE |
0407-1416 | OMNIPAQUE | OMNIPAQUE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
OMNIPAQUE 73340246 1207823 Live/Registered |
Sterling Drug Inc. 1981-12-07 |